| Analysis | Metabolite Name | Measured Value | Units | Acclimatization temperature | Heat exposure |
|---|---|---|---|---|---|
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 180616.3307 | mV*s | 10°C | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 201558.5251 | mV*s | - | group L exposure to 31°C for 3hours |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 225988.0261 | mV*s | 10°C | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 232833.4437 | mV*s | - | group L exposure to 31°C for 3hours |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 235371.3963 | mV*s | - | group L exposure to 31°C for 3hours |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 241420.1452 | mV*s | 10°C | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 250206.4621 | mV*s | 30°C | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 264329.3838 | mV*s | - | group L exposure to 31°C for 3hours |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 264857.1529 | mV*s | 10°C | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 265105.3556 | mV*s | - | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 267266.2083 | mV*s | - | group L exposure to 31°C for 3hours |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 269315.796 | mV*s | - | group L exposure to 31°C for 3hours |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 271538.8201 | mV*s | - | group H exposure to 31°C for 3hours |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 271624.3874 | mV*s | - | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 272774.9007 | mV*s | - | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 282628.5117 | mV*s | - | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 285553.2244 | mV*s | - | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 285725.3029 | mV*s | 30°C | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 290058.368 | mV*s | - | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 300108.639 | mV*s | 10°C | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 309332.9088 | mV*s | 10°C | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 312906.4785 | mV*s | 30°C | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 314827.7244 | mV*s | 30°C | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 317287.4751 | mV*s | 10°C | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 317982.4676 | mV*s | - | group H exposure to 31°C for 3hours |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 327409.2658 | mV*s | - | group H exposure to 31°C for 3hours |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 340679.4418 | mV*s | 10°C | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 348407.6116 | mV*s | - | group L exposure to 31°C for 3hours |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 372597.6379 | mV*s | 30°C | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 380842.4376 | mV*s | - | group H exposure to 31°C for 3hours |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 405069.4894 | mV*s | - | group H exposure to 31°C for 3hours |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 416348.1018 | mV*s | 30°C | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 422905.8751 | mV*s | - | group H exposure to 31°C for 3hours |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 423745.6876 | mV*s | 30°C | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 439292.451 | mV*s | - | group L exposure to 31°C for 3hours |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 444759.8371 | mV*s | - | group H exposure to 31°C for 3hours |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 478699.4002 | mV*s | - | group H exposure to 31°C for 3hours |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 480280.2007 | mV*s | - | group L exposure to 31°C for 3hours |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 485754.1512 | mV*s | 30°C | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 498689.7957 | mV*s | 30°C | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 622684.9156 | mV*s | 10°C | - |
| HILIC NEGATIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 664899.4481 | mV*s | - | group H exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 11324.1194 | mV*min | - | group H exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 11554.7168 | mV*min | 30°C | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 11698.95692 | mV*min | 10°C | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 12732.27 | mV*min | - | group H exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 14347.68 | mV*min | - | group H exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 15126.28706 | mV*min | - | group L exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 15220.4875 | mV*min | 10°C | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 16333.46229 | mV*min | - | group L exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 17336.64873 | mV*min | - | group H exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 18234.8942 | mV*min | - | group L exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 18900.78353 | mV*min | - | group L exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 19139.8872 | mV*min | - | group L exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 19370.22889 | mV*min | 10°C | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 19731.01706 | mV*min | - | group H exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 19982.39294 | mV*min | 30°C | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 20698.40594 | mV*min | - | group L exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 21149.17243 | mV*min | - | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 21353.71142 | mV*min | - | group L exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 21484.56833 | mV*min | 30°C | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 22543.51 | mV*min | 30°C | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 23272.25813 | mV*min | 10°C | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 24984.32432 | mV*min | - | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 26076.07376 | mV*min | - | group H exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 26204.4195 | mV*min | - | group L exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 26591.81568 | mV*min | - | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 26855.43542 | mV*min | - | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 27548.13012 | mV*min | - | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 27788.59524 | mV*min | - | group H exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 27935.23371 | mV*min | - | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 28624.17282 | mV*min | - | group H exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 28712.33351 | mV*min | - | group L exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 29297.98675 | mV*min | 10°C | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 29316.46789 | mV*min | 10°C | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 30563.35388 | mV*min | 10°C | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 31799.87918 | mV*min | 10°C | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 40318.42218 | mV*min | 10°C | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 43968.1889 | mV*min | - | group H exposure to 31°C for 3hours |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 47176.15189 | mV*min | 30°C | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 47648.57967 | mV*min | 30°C | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 47660.4616 | mV*min | 30°C | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 48989.95088 | mV*min | 30°C | - |
| HILIC POSITIVE ION MODE | (4Z,7Z,10Z,13Z,16Z,19Z)-4,7,10,13,1 6,19-Docosahexaenoic acid | 51030.08083 | mV*min | 30°C | - |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|